Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study of Smoking Abstinence

NCT01035632

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: National Institute on Drug Abuse, Biomedical Research Center (BRC) Baltimore, Maryland, United States

View Trial Details

Completed

AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

NCT01233687

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors

NCT01670175

Conditions: Childhood Solid Tumor, Disease Attributes, Malignant Solid Tumor, +3 more
Locations: UCSF Benioff Children's Hospital San Francisco, California, United States

View Trial Details

Completed

Cord Blood Transplantation in Severe Aplastic Anemia

NCT01343953

Conditions: Absence of an HLA Identical Donor, Acquired Aplastic Anemia, Anemia, +13 more
Locations: saint Louis Paris, France

View Trial Details

Completed

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

NCT03174912

Conditions: Bladder Cancer, Disease Attributes, Disease Progression, +15 more
Locations: Not specified

View Trial Details

Completed

Medication Development in Alcoholism: Investigating PPAR Agonists

NCT02158273

Conditions: Alcohol-Related Disorders, Alcoholism, Chemically-Induced Disorders, +6 more
Locations: Susan Quello La Jolla, California, United States

View Trial Details

Completed

Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases

NCT00362817

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +11 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)

NCT01172548

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +10 more
Locations: Novartis Investigative Site Algiers, Algeria

Novartis Investigative Site Al Mansurah, Egypt

Novartis Investigative Site Cairo, Egypt

Novartis Investigative Site Ahmedabad, Gujarat, India

View all 29 locations

View Trial Details

Completed

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT01466153

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Burbank, California, United States

Research Site La Jolla, California, United States

Research Site Palm Springs, California, United States

View all 54 locations

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions